Philip Ma, PrognomiQ CEO
PrognomiQ raises $34M for lung cancer test
PrognomiQ has raised an additional $34 million in funding as the company prepares to release its blood-based protein test for lung cancer.
The company is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
